{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:44:17Z","timestamp":1794523457969,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170986"],"award-info":[{"award-number":["32170986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671055"],"award-info":[{"award-number":["31671055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901950"],"award-info":[{"award-number":["81901950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09201002-005"],"award-info":[{"award-number":["2018ZX09201002-005"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Xu Jun \u2018s expert workstation","award":["202005AF150050"],"award-info":[{"award-number":["202005AF150050"]}]},{"name":"Association Foundation Program of Yunnan Province science and Technology Department and Kunming Medicine University","award":["2019FE001(-009)"],"award-info":[{"award-number":["2019FE001(-009)"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Association Foundation Program of Yunnan Province science and Technology Department and Kunming Medicine University","award":["202001AY07001-166"],"award-info":[{"award-number":["202001AY07001-166"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatic fibrosis is a common pathologic stage in chronic liver disease development, which might ultimately lead to liver cirrhosis. Accumulating evidence suggests that adipose-derived stromal cells (ADSCs)-based therapies show excellent therapeutic potential in liver injury disease owing to its superior properties, including tissue repair ability and immunomodulation effect. However, cell-based therapy still limits to several problems, such as engraftment efficiency and immunoreaction, which impede the ADSCs-based therapeutics development. So, ADSCs-derived extracellular vesicles (EVs), especially for exosomes (ADSC-EXO), emerge as a promise cell-free therapeutics to ameliorate liver fibrosis. The effect and underlying mechanisms of ADSC-EXO in liver fibrosis remains blurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Hepatic fibrosis murine model was established by intraperitoneal sequential injecting the diethylnitrosamine (DEN) for two weeks and then carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      ) for six weeks. Subsequently, hepatic fibrosis mice were administrated with ADSC-EXO (10\u00a0\u03bcg\/g) or PBS through tail vein infusion for three times in two weeks. To evaluate the anti-fibrotic capacity of ADSC-EXO, we detected liver morphology by histopathological examination, ECM deposition by serology test and Sirius Red staining, profibrogenic markers by qRT-PCR assay. LX-2 cells treated with TGF-\u03b2 (10\u00a0ng\/ml) for 12\u00a0h were conducted for evaluating ADSC-EXO effect on activated hepatic stellate cells (HSCs). RNA-seq was performed for further analysis of the underlying regulatory mechanisms of ADSC-EXO in liver fibrosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this study, we obtained isolated ADSCs, collected and separated ADSCs-derived exosomes. We found that ADSC-EXO treatment could efficiently ameliorate DEN\/CCl\n                      <jats:sub>4<\/jats:sub>\n                      -induced hepatic fibrosis by improving mice liver function and lessening hepatic ECM deposition. Moreover, ADSC-EXO intervention could reverse profibrogenic phenotypes both in vivo and in vitro, including HSCs activation depressed and profibrogenic markers inhibition. Additionally, RNA-seq analysis further determined that decreased glutamine synthetase (Glul) of perivenous hepatocytes in hepatic fibrosis mice could be dramatically up-regulated by ADSC-EXO treatment; meanwhile, glutamine and ammonia metabolism-associated key enzyme OAT was up-regulated and GLS2 was down-regulated by ADSC-EXO treatment in mice liver. In addition, glutamine synthetase inhibitor would erase ADSC-EXO therapeutic effect on hepatic fibrosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings demonstrated that ADSC-derived exosomes could efficiently alleviate hepatic fibrosis by suppressing HSCs activation and remodeling glutamine and ammonia metabolism mediated by hepatocellular glutamine synthetase, which might be a novel and promising anti-fibrotic therapeutics for hepatic fibrosis disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-022-03049-x","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T03:03:03Z","timestamp":1664852583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis"],"prefix":"10.1186","volume":"13","author":[{"given":"Baitong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"issue":"4","key":"3049_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.cld.2008.07.006","volume":"12","author":"M Pinzani","year":"2008","unstructured":"Pinzani M, Vizzutti F. Fibrosis and cirrhosis reversibility: clinical features and implications. Clin Liver Dis. 2008;12(4):901\u201313.","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"3049_CR2","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis \u2013 from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38-53.","journal-title":"J Hepatol"},{"issue":"4","key":"3049_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S2468-1253(16)30110-8","volume":"1","author":"P Ramachandran","year":"2016","unstructured":"Ramachandran P, Henderson NC. Antifibrotics in chronic liver disease: tractable targets and translational challenges. Lancet Gastroenterol Hepatol. 2016;1(4):328\u201340.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"3049_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/his.12957","volume":"68","author":"A Quaglia","year":"2016","unstructured":"Quaglia A, Alves VA, Balabaud C, Bhathal PS, Bioulac-Sage P, Crawford JM, et al. Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation. Histopathology. 2016;68(7):953\u201367.","journal-title":"Histopathology"},{"issue":"10","key":"3049_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3049_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","volume":"33","author":"P Trivedi","year":"2021","unstructured":"Trivedi P, Wang S, Friedman SL. The power of plasticity-metabolic regulation of hepatic stellate cells. Cell Metab. 2021;33:242\u201357.","journal-title":"Cell Metab"},{"key":"3049_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3049_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27\u201342.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7783","key":"3049_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575(7783):512\u20138.","journal-title":"Nature"},{"issue":"3","key":"3049_CR10","doi-asserted-by":"publisher","first-page":"G280","DOI":"10.1152\/ajpgi.00338.2019","volume":"321","author":"VK Pulakazhi Venu","year":"2021","unstructured":"Pulakazhi Venu VK, Alston L, Iftinca M, Tsai YC, Stephens M, Warriyar KVV, et al. Nr4A1 modulates inflammation-associated intestinal fibrosis and dampens fibrogenic signaling in myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2021;321(3):G280\u201397.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3049_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.133925","volume":"295","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Hui J, Xu Y, Ma Y, Sun Z, Zhang M, et al. MEHP promotes liver fibrosis by down-regulating STAT5A in BRL-3A hepatocytes. Chemosphere. 2022;295: 133925.","journal-title":"Chemosphere"},{"key":"3049_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00675-6","author":"E Barreby","year":"2022","unstructured":"Barreby E, Chen P, Aouadi M. Macrophage functional diversity in NAFLD\u2014more than inflammation. Nat Rev Endocrinol. 2022. https:\/\/doi.org\/10.1038\/s41574-022-00675-6.","journal-title":"Nat Rev Endocrinol"},{"key":"3049_CR13","doi-asserted-by":"publisher","first-page":"6546780","DOI":"10.1155\/2021\/6546780","volume":"2021","author":"M Zhu","year":"2021","unstructured":"Zhu M, Hua T, Ouyang T, Qian H, Yu B. Applications of mesenchymal stem cells in liver fibrosis: novel strategies, mechanisms, and clinical practice. Stem Cells Int. 2021;2021:6546780.","journal-title":"Stem Cells Int"},{"issue":"1","key":"3049_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2017.09.049","volume":"154","author":"CW Lee","year":"2018","unstructured":"Lee CW, Chen YF, Wu HH, Lee OK. Historical perspectives and advances in mesenchymal stem cell research for the treatment of liver diseases. Gastroenterology. 2018;154(1):46\u201356.","journal-title":"Gastroenterology"},{"issue":"4","key":"3049_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s12015-015-9585-9","volume":"11","author":"EJ Fiore","year":"2015","unstructured":"Fiore EJ, Mazzolini G, Aquino JB. Mesenchymal stem\/stromal cells in liver fibrosis: recent findings, old\/new caveats and future perspectives. Stem Cell Rev Rep. 2015;11(4):586\u201397.","journal-title":"Stem Cell Rev Rep"},{"issue":"8","key":"3049_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.21037\/atm.2020.03.218","volume":"8","author":"S Zhang","year":"2020","unstructured":"Zhang S, Yang Y, Fan L, Zhang F, Li L. The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future. Ann Transl Med. 2020;8(8):565.","journal-title":"Ann Transl Med"},{"key":"3049_CR17","doi-asserted-by":"crossref","unstructured":"Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008; 134(7):2111\u20132121, 2121 e2111\u20132113.","DOI":"10.1053\/j.gastro.2008.03.015"},{"key":"3049_CR18","doi-asserted-by":"publisher","first-page":"8628027","DOI":"10.1155\/2019\/8628027","volume":"2019","author":"B Li","year":"2019","unstructured":"Li B, Cheng Y, Yu S, Zang L, Yin Y, Liu J, et al. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates nonalcoholic fatty liver disease in obese type 2 diabetic mice. Stem Cells Int. 2019;2019:8628027.","journal-title":"Stem Cells Int"},{"issue":"1","key":"3049_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13287-019-1310-1","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu C, Zhao L, Li L. Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Res Ther. 2019;10(1):199.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3049_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00005-016-0394-x","volume":"64","author":"A Bajek","year":"2016","unstructured":"Bajek A, Gurtowska N, Olkowska J, Kazmierski L, Maj M, Drewa T. Adipose-derived stem cells as a tool in cell-based therapies. Arch Immunol Ther Exp (Warsz). 2016;64(6):443\u201354.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"2","key":"3049_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/157488810791268564","volume":"5","author":"AJ Salgado","year":"2010","unstructured":"Salgado AJ, Reis RL, Sousa NJ, Gimble JM. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther. 2010;5(2):103\u201310.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"8","key":"3049_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41419-019-1772-1","volume":"10","author":"S Gao","year":"2019","unstructured":"Gao S, Guo X, Zhao S, Jin Y, Zhou F, Yuan P, et al. Differentiation of human adipose-derived stem cells into neuron\/motoneuron-like cells for cell replacement therapy of spinal cord injury. Cell Death Dis. 2019;10(8):597.","journal-title":"Cell Death Dis"},{"issue":"7\u20138","key":"3049_CR23","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1089\/ten.tea.2012.0773","volume":"20","author":"S Gao","year":"2014","unstructured":"Gao S, Zhao P, Lin C, Sun Y, Wang Y, Zhou Z, et al. Differentiation of human adipose-derived stem cells into neuron-like cells which are compatible with photocurable three-dimensional scaffolds. Tissue Eng Part A. 2014;20(7\u20138):1271\u201384.","journal-title":"Tissue Eng Part A"},{"issue":"1","key":"3049_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13287-016-0412-2","volume":"7","author":"R Shi","year":"2016","unstructured":"Shi R, Jin Y, Cao C, Han S, Shao X, Meng L, et al. Localization of human adipose-derived stem cells and their effect in repair of diabetic foot ulcers in rats. Stem Cell Res Ther. 2016;7(1):155.","journal-title":"Stem Cell Res Ther"},{"issue":"21","key":"3049_CR25","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1089\/scd.2019.0113","volume":"28","author":"X Zhou","year":"2019","unstructured":"Zhou X, Ning K, Ling B, Chen X, Cheng H, Lu B, et al. Multiple injections of autologous adipose-derived stem cells accelerate the burn wound healing process and promote blood vessel regeneration in a rat model. Stem Cells Dev. 2019;28(21):1463\u201372.","journal-title":"Stem Cells Dev"},{"key":"3049_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13287-015-0078-1","volume":"6","author":"F Zhou","year":"2015","unstructured":"Zhou F, Gao S, Wang L, Sun C, Chen L, Yuan P, et al. Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model. Stem Cell Res Ther. 2015;6:92.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"3049_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851\u20138.","journal-title":"Stem Cells"},{"issue":"1","key":"3049_CR28","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"key":"3049_CR29","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):aau6977.","DOI":"10.1126\/science.aau6977"},{"key":"3049_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ebiom.2018.08.054","volume":"36","author":"Y Liu","year":"2018","unstructured":"Liu Y, Lou G, Li A, Zhang T, Qi J, Ye D, et al. AMSC-derived exosomes alleviate lipopolysaccharide\/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP\/NLRP3 inflammasome activation in macrophages. EBioMedicine. 2018;36:140\u201350.","journal-title":"EBioMedicine"},{"issue":"4","key":"3049_CR31","first-page":"1543","volume":"9","author":"CK Sun","year":"2017","unstructured":"Sun CK, Chen CH, Chang CL, Chiang HJ, Sung PH, Chen KH, et al. Melatonin treatment enhances therapeutic effects of exosomes against acute liver ischemia-reperfusion injury. Am J Transl Res. 2017;9(4):1543\u201360.","journal-title":"Am J Transl Res"},{"key":"3049_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ebiom.2018.07.015","volume":"34","author":"Y Jin","year":"2018","unstructured":"Jin Y, Wang J, Li H, Gao S, Shi R, Yang D, et al. Extracellular Vesicles secreted by human adipose-derived stem cells (hASCs) improve survival rate of rats with acute liver failure by releasing lncRNA H19. EBioMedicine. 2018;34:231\u201342.","journal-title":"EBioMedicine"},{"issue":"2","key":"3049_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/acer.12239","volume":"38","author":"EC El Hajj","year":"2014","unstructured":"El Hajj EC, El Hajj MC, Voloshenyuk TG, Mouton AJ, Khoutorova E, Molina PE, et al. Alcohol modulation of cardiac matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs favors collagen accumulation. Alcohol Clin Exp Res. 2014;38(2):448\u201356.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"3049_CR34","first-page":"2382","volume":"11","author":"SS Lai","year":"2019","unstructured":"Lai SS, Fu X, Cheng Q, Yu ZH, Jiang EZ, Zhao DD, et al. HSC-specific knockdown of GGPPS alleviated CCl4-induced chronic liver fibrosis through mediating RhoA\/Rock pathway. Am J Transl Res. 2019;11(4):2382\u201392.","journal-title":"Am J Transl Res"},{"issue":"4","key":"3049_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0168-8278(00)00059-3","volume":"34","author":"S Tada","year":"2001","unstructured":"Tada S, Iwamoto H, Nakamuta M, Sugimoto R, Enjoji M, Nakashima Y, et al. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol. 2001;34(4):529\u201336.","journal-title":"J Hepatol"},{"key":"3049_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2741\/2070","volume":"12","author":"D Haussinger","year":"2007","unstructured":"Haussinger D, Schliess F. Glutamine metabolism and signaling in the liver. Front Biosci. 2007;12:371\u201391.","journal-title":"Front Biosci"},{"issue":"3","key":"3049_CR37","doi-asserted-by":"publisher","first-page":"857S","DOI":"10.3945\/ajcn.2009.27462Z","volume":"90","author":"ME Brosnan","year":"2009","unstructured":"Brosnan ME, Brosnan JT. Hepatic glutamate metabolism: a tale of 2 hepatocytes. Am J Clin Nutr. 2009;90(3):857S-861S.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"3049_CR38","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1515\/hsz-2021-0166","volume":"402","author":"B Frieg","year":"2021","unstructured":"Frieg B, Gorg B, Gohlke H, Haussinger D. Glutamine synthetase as a central element in hepatic glutamine and ammonia metabolism: novel aspects. Biol Chem. 2021;402(9):1063\u201372.","journal-title":"Biol Chem"},{"issue":"4","key":"3049_CR39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/liv.12099","volume":"33","author":"KE Fleming","year":"2013","unstructured":"Fleming KE, Wanless IR. Glutamine synthetase expression in activated hepatocyte progenitor cells and loss of hepatocellular expression in congestion and cirrhosis. Liver Int. 2013;33(4):525\u201334.","journal-title":"Liver Int"},{"issue":"1","key":"3049_CR40","first-page":"18","volume":"6","author":"A Ginguay","year":"2017","unstructured":"Ginguay A, Cynober L, Curis E, Nicolis I. Ornithine aminotransferase, an important glutamate-metabolizing enzyme at the crossroads of multiple metabolic pathways. Biology (Basel). 2017;6(1):18.","journal-title":"Biology (Basel)."},{"issue":"8","key":"3049_CR41","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/MCG.0000000000000208","volume":"49","author":"S Scaglione","year":"2015","unstructured":"Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, et al. The Epidemiology of Cirrhosis in the United States: a Population-based Study. J Clin Gastroenterol. 2015;49(8):690\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"3049_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"key":"3049_CR43","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.2147\/DDDT.S220190","volume":"13","author":"S Zhao","year":"2019","unstructured":"Zhao S, Liu Y, Pu Z. Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN\/LPS-induced hepatocyte apoptosis by activating autophagy in vitro. Drug Des Devel Ther. 2019;13:2887\u201397.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"3049_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jphs.2021.06.008","volume":"147","author":"HY Wu","year":"2021","unstructured":"Wu HY, Zhang XC, Jia BB, Cao Y, Yan K, Li J, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acetaminophen-induced acute liver failure through activating ERK and IGF-1R\/PI3K\/AKT signaling pathway. J Pharmacol Sci. 2021;147(1):143\u201355.","journal-title":"J Pharmacol Sci"},{"key":"3049_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117401","volume":"246","author":"S Zhang","year":"2020","unstructured":"Zhang S, Jiang L, Hu H, Wang H, Wang X, Jiang J, et al. Pretreatment of exosomes derived from hUCMSCs with TNF-alpha ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage. Life Sci. 2020;246: 117401.","journal-title":"Life Sci"},{"issue":"4","key":"3049_CR46","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41419-022-04764-2","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, Huang Y, Mei R, Mao F, Yang D, Liu J, et al. HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT\/GPX4 axis. Cell Death Dis. 2022;13(4):319.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3049_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12951-021-01138-2","volume":"19","author":"N Wang","year":"2021","unstructured":"Wang N, Li X, Zhong Z, Qiu Y, Liu S, Wu H, et al. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFbetaRII-SMADS pathway. J Nanobiotechnology. 2021;19(1):437.","journal-title":"J Nanobiotechnology"},{"issue":"8","key":"3049_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12085","volume":"10","author":"M Kang","year":"2021","unstructured":"Kang M, Jordan V, Blenkiron C, Chamley LW. Biodistribution of extracellular vesicles following administration into animals: a systematic review. J Extracell Vesicles. 2021;10(8): e12085.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"3049_CR49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/10717544.2022.2030428","volume":"29","author":"L Ma","year":"2022","unstructured":"Ma L, Wei J, Zeng Y, Liu J, Xiao E, Kang Y, et al. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p\/PTEN\/AKT pathway in human liver fibrosis. Drug Deliv. 2022;29(1):440\u201353.","journal-title":"Drug Deliv"},{"issue":"6","key":"3049_CR50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3390\/nu14061133","volume":"14","author":"MP Scavo","year":"2022","unstructured":"Scavo MP, Depalo N, Rizzi F, Carrieri L, Serino G, Franco I, et al. Exosomal FZD-7 Expression is modulated by different lifestyle interventions in patients with NAFLD. Nutrients. 2022;14(6):1133.","journal-title":"Nutrients"},{"issue":"1","key":"3049_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/hep.28852","volume":"65","author":"TB Hakvoort","year":"2017","unstructured":"Hakvoort TB, He Y, Kulik W, Vermeulen JL, Duijst S, Ruijter JM, et al. Pivotal role of glutamine synthetase in ammonia detoxification. Hepatology. 2017;65(1):281\u201393.","journal-title":"Hepatology"},{"issue":"2","key":"3049_CR52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1432-1033.1988.tb14209.x","volume":"175","author":"D Haussinger","year":"1988","unstructured":"Haussinger D, Stehle T. Hepatocyte heterogeneity in response to icosanoids. The perivenous scavenger cell hypothesis. Eur J Biochem. 1988;175(2):395\u2013403.","journal-title":"Eur J Biochem"},{"issue":"17","key":"3049_CR53","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1073\/pnas.1423968112","volume":"112","author":"N Qvartskhava","year":"2015","unstructured":"Qvartskhava N, Lang PA, Gorg B, Pozdeev VI, Ortiz MP, Lang KS, et al. Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase. Proc Natl Acad Sci U S A. 2015;112(17):5521\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3049_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2022.114548","volume":"641","author":"A Schrimpf","year":"2022","unstructured":"Schrimpf A, Knappe O, Qvartskhava N, Poschmann G, Stuhler K, Bidmon HJ, et al. Hyperammonemia-induced changes in the cerebral transcriptome and proteome. Anal Biochem. 2022;641: 114548.","journal-title":"Anal Biochem"},{"key":"3049_CR55","doi-asserted-by":"publisher","first-page":"40190","DOI":"10.1038\/srep40190","volume":"7","author":"AN Chepkova","year":"2017","unstructured":"Chepkova AN, Sergeeva OA, Gorg B, Haas HL, Klocker N, Haussinger D. Impaired novelty acquisition and synaptic plasticity in congenital hyperammonemia caused by hepatic glutamine synthetase deficiency. Sci Rep. 2017;7:40190.","journal-title":"Sci Rep"},{"issue":"2","key":"3049_CR56","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj2670281","volume":"267","author":"D Haussinger","year":"1990","unstructured":"Haussinger D. Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem J. 1990;267(2):281\u201390.","journal-title":"Biochem J"},{"issue":"3","key":"3049_CR57","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41379-019-0346-1","volume":"33","author":"R Hadi","year":"2020","unstructured":"Hadi R, Shin K, Reder N, Alpert L, Koch L, Choi WT, et al. Utility of glutamine synthetase immunohistochemistry in identifying features of regressed cirrhosis. Mod Pathol. 2020;33(3):448\u201355.","journal-title":"Mod Pathol"},{"key":"3049_CR58","doi-asserted-by":"publisher","first-page":"26316","DOI":"10.3402\/jev.v4.26316","volume":"4","author":"OP Wiklander","year":"2015","unstructured":"Wiklander OP, Nordin JZ, O\u2019Loughlin A, Gustafsson Y, Corso G, M\u00e4ger I, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316.","journal-title":"J Extracell Vesicles"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03049-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T04:09:00Z","timestamp":1664856540000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03049-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3049"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03049-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"27 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by the Animal Committee of the School (Tongji University, Shanghai, People\u2019s Republic of China, TJmed-010-10). The approval No. was TJAA07620401. Adipose tissue for experiments was collected by liposuction operation from young healthy donors, which had approved by the ethical committee of the People's Liberation Army No. 85 Hospital, Shanghai, P.R. China (review serial number NO.2013\/18). All participants signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"494"}}